117 related articles for article (PubMed ID: 24259626)
1. Salmon calcitonin use and associated cancer risk.
Overman RA; Borse M; Gourlay ML
Ann Pharmacother; 2013 Dec; 47(12):1675-84. PubMed ID: 24259626
[TBL] [Abstract][Full Text] [Related]
2. Calcitonin intranasal--unigene: Salcatonin intranasal--unigene.
Drugs R D; 2004; 5(2):90-3. PubMed ID: 15293868
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamics and pharmacokinetics of oral salmon calcitonin in the treatment of osteoporosis.
Bandeira L; Lewiecki EM; Bilezikian JP
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):681-9. PubMed ID: 27070719
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D.
Henriksen K; Byrjalsen I; Andersen JR; Bihlet AR; Russo LA; Alexandersen P; Valter I; Qvist P; Lau E; Riis BJ; Christiansen C; Karsdal MA;
Bone; 2016 Oct; 91():122-9. PubMed ID: 27462009
[TBL] [Abstract][Full Text] [Related]
6. A randomized trial of nasal spray salmon calcitonin in men with idiopathic osteoporosis: effects on bone mineral density and bone markers.
Trovas GP; Lyritis GP; Galanos A; Raptou P; Constantelou E
J Bone Miner Res; 2002 Mar; 17(3):521-7. PubMed ID: 11874243
[TBL] [Abstract][Full Text] [Related]
7. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
Binkley N; Bolognese M; Sidorowicz-Bialynicka A; Vally T; Trout R; Miller C; Buben CE; Gilligan JP; Krause DS;
J Bone Miner Res; 2012 Aug; 27(8):1821-9. PubMed ID: 22437792
[TBL] [Abstract][Full Text] [Related]
8. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.
Reginster JY; Deroisy R; Lecart MP; Sarlet N; Zegels B; Jupsin I; de Longueville M; Franchimont P
Am J Med; 1995 May; 98(5):452-8. PubMed ID: 7733123
[TBL] [Abstract][Full Text] [Related]
9. The analgesic role of calcitonin following osteoporotic fracture.
Silverman SL; Azria M
Osteoporos Int; 2002 Nov; 13(11):858-67. PubMed ID: 12415432
[TBL] [Abstract][Full Text] [Related]
10. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 9. Calcitonin in the treatment of osteoporosis.
Siminoski K; Josse RG
CMAJ; 1996 Oct; 155(7):962-5. PubMed ID: 8837547
[TBL] [Abstract][Full Text] [Related]
11. Analgesic efficacy of calcitonin for vertebral fracture pain.
Blau LA; Hoehns JD
Ann Pharmacother; 2003 Apr; 37(4):564-70. PubMed ID: 12659616
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and evaluation of bone targeting salmon calcitonin analogs in normal and osteoporotic rats.
Bhandari KH; Newa M; Chapman J; Doschak MR
J Control Release; 2012 Feb; 158(1):44-52. PubMed ID: 22001608
[TBL] [Abstract][Full Text] [Related]
13. Oral salmon calcitonin--pharmacology in osteoporosis.
Henriksen K; Bay-Jensen AC; Christiansen C; Karsdal MA
Expert Opin Biol Ther; 2010 Nov; 10(11):1617-29. PubMed ID: 20932224
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of combined salmon calcitonin and aspirin therapy for osteoporosis in ovariectomized rats.
Wei J; Wang J; Gong Y; Zeng R
Mol Med Rep; 2015 Aug; 12(2):1717-26. PubMed ID: 25891179
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of treatment with salmon calcitonin, administered intranasally for 1 year, in stabilized postmenopausal osteoporosis].
Agnusdei D; Gonnelli S; Camporeale A; Batignani T; Nardi P; Ianes A; Gennari C
Minerva Endocrinol; 1989; 14(3):169-76. PubMed ID: 2695815
[TBL] [Abstract][Full Text] [Related]
16. Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep.
Hinchcliffe M; Jabbal-Gill I; Smith A
J Pharm Pharmacol; 2005 Jun; 57(6):681-7. PubMed ID: 15969922
[TBL] [Abstract][Full Text] [Related]
17. Effect of nasal salmon calcitonin on calcium and bone metabolism.
Thamsborg G
Dan Med Bull; 1999 Apr; 46(2):118-26. PubMed ID: 10327295
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis.
Tekeoğlu I; Adak B; Budancamanak M; Demirel A; Ediz L
Rheumatol Int; 2005 Dec; 26(2):157-61. PubMed ID: 15660234
[TBL] [Abstract][Full Text] [Related]
19. Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis.
Bagger YZ; Tankó LB; Alexandersen P; Karsdal MA; Olson M; Mindeholm L; Azria M; Christiansen C
Bone; 2005 Sep; 37(3):425-30. PubMed ID: 16005273
[TBL] [Abstract][Full Text] [Related]
20. Proliferative pituitary lesions in rats treated with salmon or porcine calcitonin.
Brown WR; Fetter AD; Van Ryzin RJ; Langloss JM
Toxicol Pathol; 1993; 21(1):81-6. PubMed ID: 8378709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]